Saltar al contenido
medico.doctor

Martes 29 de septiembre de 2026 · 152 publicaciones en las últimas 24 h · 29 fuentes · actualizado hace 24 min

Nature Medicine: últimas publicaciones

Revista de investigación biomédica con revisión por pares. Revista científica · Internacional · Sitio oficial.

8 notas · Solo en español

NatMedNature MedicineRevista científicaEN

Oral small-molecule GLP-1 receptor agonist safiglipron in early type 2 diabetes: a randomized, double-blind, placebo-controlled trial

Nature Medicine, Published online: 29 September 2026; doi:10.1038/s41591-026-04651-9 The OUTSTAND-1 trial showed that once-daily oral small-molecule GLP-1 receptor agonist safiglipron reduced HbA1c by up to 1.45% versus placebo over 32 weeks in people with type 2 diabetes without glucose-lowering medication while body weight effects were…

Diabetes, obesidad y metabolismo

NatMedNature MedicineRevista científicaEN

Werner helicase inhibitor for advanced microsatellite instability solid tumors: a phase 1 trial

Nature Medicine, Published online: 29 September 2026; doi:10.1038/s41591-026-04657-3 In the dose-escalation stage of a phase 1 trial evaluating RO7589831, a first-in-class inhibitor of the synthetic lethal target Werner syndrome helicase, in patients with microsatellite instability and/or DNA mismatch repair-deficient solid tumors, the maximum tolerated dose…

Oncología

NatMedNature MedicineRevista científicaEN

Reproducibility in biomedical research

Nature Medicine, Published online: 29 September 2026; doi:10.1038/s41591-026-04667-1 Reproducibility is a foundational principle of trustworthy science, but reproducible research practices are not consistently implemented. This Review summarizes the current landscape including efforts to harmonize terminology and implementation, persistent barriers and ecosystem responses.

NatMedNature MedicineRevista científicaEN

Prime editing goes large

Nature Medicine, Published online: 28 September 2026; doi:10.1038/d41591-026-00049-9 A technique known as prime assembly expands the capabilities of prime editing, allowing larger genome rearrangements and potentially wider clinical applications.